バイオグラフィー
DEEPA RICH advises emerging and high-growth biotechnology, medical device, diagnostics, healthcare, and digital health companies on corporate transactions globally. She also regularly represents venture capital funds and underwriters in the life sciences industry.
Deepa has extensive experience advising companies and investors on financings, ranging from seed investments and venture capital financings, to crossover financings and public company securities offerings, including initial traditional public offerings, reverse mergers, SPAC and de-SPAC transactions, follow-on offerings, confidentially marketed public offerings, registered direct offerings, private investments in public equity, and at-the-market offerings. She also advises buyers and sellers on mergers and acquisitions, strategic alliances, joint ventures, and divestitures, and handles regulatory matters involving the U.S. Securities and Exchange Commission (SEC) and stock exchanges.
Deepa counsels management teams and boards of directors on corporate governance and strategic matters, including general corporate and startup issues, public company reporting, market communications, regulatory matters, acquisitions, corporate development, and capital markets strategies.
Deepa was recognized by The Daily Journal as a “Top Healthcare Lawyer” (2020–2022).
資格
- California
- Santa Clara University School of Law, 法務博士
- Arizona State University, 理学士